Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 5kWORD 23k
20 March 2015
Question for written answer E-004508-15
to the Commission
Rule 130
Lidia Senra Rodríguez (GUE/NGL)

 Subject:  Multiple Chemical Sensitivity
 Answer in writing 

Multiple Chemical Sensitivity (MCS) is a condition characterised by recurrent symptoms attributed to a range of chemical substances, which affects various parts of the body including the central nervous system, circulation and respiratory system, and causes irritation of the mucous membranes as well as metabolic, endocrinological or gastrointestinal disorders.

Those affected by this condition suffer reactions when exposed to chemicals such as perfumes, insecticides, varnish, detergents, multipurpose cleaning and scouring products, petrol, glues, and the like.

It is a fact that the vast majority of those diagnosed are women, and it is also true that many sufferers go through difficult ordeals to obtain a diagnosis (they are often treated as if they are hysterical) and to find clinics that follow the relevant care protocols.

Does the Commission have any information on the current situation as regards diagnosis and protocols in Spain, and in Galicia?

What does the Commission plan to do to guarantee that care protocols are provided in the public health system for MCS sufferers?

Original language of question: ES 
Legal notice - Privacy policy